{"id":2517,"date":"2020-01-28T13:24:06","date_gmt":"2020-01-28T13:24:06","guid":{"rendered":"https:\/\/plaza.umin.ac.jp\/~ACP\/?page_id=2517"},"modified":"2020-01-28T13:24:06","modified_gmt":"2020-01-28T13:24:06","slug":"itc_103_heart-failure%e3%81%ae%e7%94%a8%e8%aa%9e%e7%b5%b1%e4%b8%80%e6%a1%88","status":"publish","type":"page","link":"https:\/\/plaza.umin.ac.jp\/~ACP\/itc_103_heart-failure%e3%81%ae%e7%94%a8%e8%aa%9e%e7%b5%b1%e4%b8%80%e6%a1%88","title":{"rendered":"ITC_103_Heart Failure\u306e\u7528\u8a9e\u7d71\u4e00\u6848"},"content":{"rendered":"\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
\u539f\u8a9e<\/th>\u7528\u8a9e\u7d71\u4e00\u6848<\/th>\u601d\u8003\u904e\u7a0b<\/th>\n<\/tr>\n<\/thead>\n
ACE inhibitors<\/td>ACE\u963b\u5bb3\u85ac
\n\u203b\u521d\u51fa\u6642\uff08angiotensin-converting enzyme inhibitor\uff09\u306f\u30a2\u30f3\u30b8\u30aa\u30c6\u30f3\u30b7\u30f3\u5909\u63db\u9175\u7d20\u963b\u5bb3\u85ac<\/td>		\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
adverse effect<\/td>\u6709\u5bb3\u4e8b\u8c61<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
adverse event<\/td>\u6709\u5bb3\u4e8b\u8c61<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
all cause mortality<\/td>\u5168\u6b7b\u4ea1\u7387<\/td>\u5404\u7a2e\u7528\u8a9e\u96c6\u306b\u8a18\u8f09\u306a\u3057\u3002\u8a33\u672c\u3084Net\u3067\u306f\u5168\u6b7b\u4ea1\u7387\u3001\u5168\u6b7b\u56e0\u6b7b\u4ea1\u7387\u3044\u305a\u308c\u304b\u306e\u30d1\u30bf\u30fc\u30f3\u3002<\/td>\n<\/tr>\n
ARB<\/td>ARB
\n\u203b\u521d\u51fa\u6642(Angiotensin-receptor blockers)\u306f\u30a2\u30f3\u30b8\u30aa\u30c6\u30f3\u30b7\u30f3\u53d7\u5bb9\u4f53\u62ee\u6297\u85ac<\/td>		\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
Borderline diastolic heart failure<\/td>\u5883\u754c\u578b\u62e1\u5f35\u671f\u5fc3\u4e0d\u5168<\/td>\u5404\u7a2e\u7528\u8a9e\u96c6\u306b\u8a18\u8f09\u306a\u3057\u3002<\/td>\n<\/tr>\n
bumetanide<\/td>\u30d6\u30e1\u30bf\u30cb\u30c9<\/td>NIHS<\/td>\n<\/tr>\n
cardiopulmonary exercise testing <\/td>\u5fc3\u80ba\u904b\u52d5\u8ca0\u8377\u8a66\u9a13<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
cardiovascular death<\/td>\u5fc3\u8840\u7ba1\u6b7b<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6\u3067cardiovascular disease mortality\u304c\u5fc3\u8840\u7ba1\u75be\u60a3\u6b7b\u4ea1\u7387<\/td>\n<\/tr>\n
catheterization\t<\/td>\u30ab\u30c6\u30fc\u30c6\u30eb\u6cd5<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
coronary [artery] revascularization<\/td>\u51a0\u52d5\u8108\u8840\u884c\u518d\u5efa\u8853<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
coronary artery disease<\/td>\u51a0\u52d5\u8108\u75be\u60a3<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
diastolic dysfunction<\/td>\u62e1\u5f35\u6a5f\u80fd\u969c\u5bb3<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
diastolic heart failure<\/td>\u62e1\u5f35\u671f\u5fc3\u4e0d\u5168<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
early satiety<\/td>\u65e9\u671f\u6e80\u8179\u611f<\/td>\u6d88\u5316\u5668\u75c5\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
EF<\/td>\u5de6\u5ba4\u99c6\u51fa\u7387<\/td>\u30dd\u30b1\u30ec\u30d5\u30a1\u5317\u91ce\u5148\u751f\u8cc7\u6599<\/td>\n<\/tr>\n
endomyocardial biopsy <\/td>\u5fc3\u5185\u819c\u5fc3\u7b4b\u751f\u691c<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
functional capacity<\/td>\u5fc3\u6a5f\u80fd\u5206\u985e<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
functional status<\/td>\u6a5f\u80fd\u72b6\u614b<\/td>\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u8f9e\u66f8<\/td>\n<\/tr>\n
giant cell myocarditis<\/td>\u5de8\u7d30\u80de\u5fc3\u7b4b\u708e<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
hemodynamic monitoring<\/td>\u8840\u884c\u529b\u5b66\u30e2\u30cb\u30bf\u30fc<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
Hydralazine <\/td>\u30d2\u30c9\u30e9\u30e9\u30b8\u30f3<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
isosorbide dinitrate<\/td>\u785d\u9178\u30a4\u30bd\u30bd\u30eb\u30d3\u30c9<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
iron overload<\/td>\u9244\u904e\u5270<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
Ivabradine<\/td>\u30a4\u30d0\u30d6\u30e9\u30b8\u30f3<\/td>\u5c0f\u91ce\u85ac\u54c1\u306e\u30b5\u30a4\u30c8\u3088\u308ahttps:\/\/www.ono.co.jp\/jpnw\/PDF\/n12_0217.pdf<\/td>\n<\/tr>\n
lifestyle modification<\/td>\u751f\u6d3b\u7fd2\u6163\u6539\u5584<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
magnetic resonance imaging<\/td>\u78c1\u6c17\u5171\u9cf4\u50cf<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
mechanical circulatory support<\/td>\u6a5f\u68b0\u7684\u5faa\u74b0\u88dc\u52a9<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
medical therapy<\/td>\u85ac\u7269\u7642\u6cd5<\/td>\u85ac\u7269\u7642\u6cd5\uff08ITC-AS\uff09\u3001\u5185\u79d1\u6cbb\u7642\uff08\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6\uff09<\/td>\n<\/tr>\n
nitrates<\/td>\u785d\u9178\u5869\u85ac<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
NYHA class I-IV<\/td>NYHA\u5206\u985e I-IV\u5ea6<\/td>\u5fc3\u4e0d\u5168\u30ac\u30a4\u30c9\u30e9\u30a4\u30f32018<\/td>\n<\/tr>\n
optimal medical therapy<\/td>\u81f3\u9069\uff08\u306a\uff09\u85ac\u7269\u6cbb\u7642<\/td>\u5b89\u5b9a\u51a0\u52d5\u8108\u75be\u60a3\u306e\u8840\u884c\u518d\u5efa\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3<\/td>\n<\/tr>\n
overload<\/td>\u904e\u8ca0\u8377<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
performance measure<\/td>\u30d1\u30d5\u30a9\u30fc\u30de\u30f3\u30b9\u306e\u5c3a\u5ea6<\/td>http:\/\/qi.ncc.go.jp\/basis.html<\/td>\n<\/tr>\n
Peripartum cardiomyopathy<\/td>\u5468\u7523\u671f\u5fc3\u7b4b\u75c7<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
pressure overload<\/td>\u5727\u8ca0\u8377<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
quality indicator<\/td>\u8a3a\u7642\u306e\u8cea\u8a55\u4fa1\u6307\u6a19<\/td>http:\/\/qi.ncc.go.jp\/basis.html<\/td>\n<\/tr>\n
Radionuclide ventriculography<\/td>\u653e\u5c04\u6027\u6838\u7a2e\u5fc3\u5ba4\u9020\u5f71[\u6cd5]<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
randomized controlled trial<\/td>\u7121\u4f5c\u70ba\u5316\u6bd4\u8f03\u8a66\u9a13<\/td>\u7528\u8a9e\u96c6
\nhttps:\/\/drive.google.com\/file\/d\/0BxAM-_BhUeMHUlQ2RUQ4aWpJUlk\/view<\/td>\n<\/tr>\n
randomized trial<\/td>\u7121\u4f5c\u70ba\u5316\u8a66\u9a13<\/td>\u7528\u8a9e\u96c6
\nhttps:\/\/drive.google.com\/file\/d\/0BxAM-_BhUeMHUlQ2RUQ4aWpJUlk\/view<\/td>\n<\/tr>\n
risk factor<\/td>\u5371\u967a\u56e0\u5b50<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
sacubitril<\/td>\u30b5\u30af\u30d3\u30c8\u30ea\u30eb<\/td>NIHS<\/td>\n<\/tr>\n
sinus rate<\/td>\u6d1e\u62cd\u6570\/\u6d1e\u5fc3\u62cd\u6570<\/td>\u5c0f\u5150\u79d1\u7528\u8a9e\u96c6 \u7b2c\uff12\u7248 <\/td>\n<\/tr>\n
stress testing<\/td>\u8ca0\u8377\u8a66\u9a13[\u6cd5]<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
systolic dysfunction<\/td>\u53ce\u7e2e\u6a5f\u80fd\u969c\u5bb3<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
systolic heart failure<\/td>\u53ce\u7e2e\u6027\u5fc3\u4e0d\u5168<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
Torsemide<\/td>\u30c8\u30e9\u30bb\u30df\u30c9<\/td>NIHS
\nTorsemide (USP); Torasemide (JAN\/INN)<\/td>\n<\/tr>\n
trastuzumab<\/td>\u30c8\u30e9\u30b9\u30c4\u30ba\u30de\u30d6<\/td>\u30cf\u30fc\u30bb\u30d7\u30c1\u30f3\u6dfb\u4ed8\u6587\u66f8<\/td>\n<\/tr>\n
ventricular dysfunction<\/td>\u5fc3\u5ba4\u6a5f\u80fd\u969c\u5bb3<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n
ventricular dyssynchrony<\/td>\u5fc3\u5ba4\u540c\u671f\u4e0d\u5168<\/td>\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u8f9e\u66f8<\/td>\n<\/tr>\n
volume overload<\/td>\u5bb9\u7a4d\u8ca0\u8377<\/td>\u5faa\u74b0\u5668\u5b66\u7528\u8a9e\u96c6<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"jetpack_post_was_ever_published":false,"footnotes":""},"class_list":["post-2517","page","type-page","status-publish","hentry"],"aioseo_notices":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/P9nUTT-EB","jetpack_likes_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/plaza.umin.ac.jp\/~ACP\/wp-json\/wp\/v2\/pages\/2517","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/plaza.umin.ac.jp\/~ACP\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/plaza.umin.ac.jp\/~ACP\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/plaza.umin.ac.jp\/~ACP\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/plaza.umin.ac.jp\/~ACP\/wp-json\/wp\/v2\/comments?post=2517"}],"version-history":[{"count":1,"href":"https:\/\/plaza.umin.ac.jp\/~ACP\/wp-json\/wp\/v2\/pages\/2517\/revisions"}],"predecessor-version":[{"id":2518,"href":"https:\/\/plaza.umin.ac.jp\/~ACP\/wp-json\/wp\/v2\/pages\/2517\/revisions\/2518"}],"wp:attachment":[{"href":"https:\/\/plaza.umin.ac.jp\/~ACP\/wp-json\/wp\/v2\/media?parent=2517"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}